Stephen H. Thorne

Stephen H. Thorne is the current Chief Scientific Officer at KaliVir Immunotherapeutics. Prior to this, they were with Duo Oncology, Western Oncolytics Ltd., and Stanford University. Dr. Thorne obtained their Ph.D. in Cellular and Molecular Biology from Imperial College London in 1999 and did their postdoctoral training at Cancer Research UK from 2000-2002. Stephen has been working in the field of cancer research for over 20 years and their work has been published in multiple peer-reviewed journals.

Stephen H. Thorne reports to Helena Chaye, Chief Executive Officer. Some of their coworkers include James M. Burke - Chief Medical Officer.